4/A
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-023735
President and CEO bought 21,547 shares at an average $5.91 ($127,449)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2019-09-13 | Purchase | +18,547 | $5.90 | $109,359 | 597,538 | D |
| Brady Todd C President and CEO | 2019-09-16 | Purchase | +3,000 | $6.03 | $18,090 | 600,538 | D |
| Open-market purchases · 21,547 sh · avg $5.91 · $127,449 | |||||||
Loading xslF345X03/doc4a.xml…